drugset / Trial / NCT00168870

Study of Metastatic Ocular Melanoma

NCT00168870

Phase 2 Unknown 48 enrolled Charite University, Berlin, Germany
RandomizedParallel-groupOpen-labelTreatment

Summary

This study evaluates treatment with combination versus monotherapy for patients with metastatic ocular melanoma.

Timeline

Start
2003-02
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Gemcitabine Small molecule
Subject Treosulfan Small molecule

Indications